Population Health Research Brief Series

Lerner Chair and Director Shannon Monnat, colleagues awarded $1.9 million dollar NIDA grant

Syracuse University’s Shannon Monnat(PI), Jennifer Karas Montez (co-I), Doug Wolf (co-I), and Emily Wiemers (co-I) along with colleague David Wheeler from VCU were awarded a 1.9 million dollar grant from the National Institute on Drug Abuse.

The overarching objective of the project is to identify how the policies U.S. states enacted to combat the spread and adverse effects of COVID-19 may have affected psychological health and mortality from drug overdose and suicide among working-age and older adults in both the immediate and longer terms. The project will provide novel large-scale data on adult COVID-19 experiences and wellbeing and use the variation in policy responses across states to shed light on which policies and combinations of policies are consequential for adult psychological health and related mortality, the mechanisms through which policies affect those outcomes, and the population subgroups that are disproportionately affected. The overall findings will be essential for informing optimal policy responses in future pandemics.

Lerner Faculty Affiliate Dessa Bergen-Cico Granted NSF Funding to Support Recovery from Opioid Use Disorder

Dessa Bergen-Cico, professor Public Health is the co-principal investigator along with principal investigator Asif Salekin, assistant professor  Electrical Engineering and Computer Science on a novel grant from the National Science Foundation (NSF) titled Psychophysiological Sensing to Enhance Mindfulness-Based Interventions for Self-Regulation of Opioid Cravings. This study aims to support recovery from opioid use disorder (OUD), a leading public health problem in the U.S. Dr Bergen-Cico and Dr. Salekin will lead the development of wearable physiological sensing technologies that will help identify individual predictors of craving and relapse risk while also teaching participants how to use mindfulness-based practices to manage cravings and reduce neurophysiological responses associated with stress and relapse risks.  You can read a more detailed description here https://www.nsf.gov/awardsearch/showAward?AWD_ID=2124285&HistoricalAwards=false